Ji Bing, Hosseini Zahra, Wang Liya, Zhou Lei, Tu Xinhua, Mao Hui
Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
MR R&D Collaboration, Siemens Medical Solutions Inc., Atlanta, Georgia, USA.
NMR Biomed. 2021 Jun;34(6):e4497. doi: 10.1002/nbm.4497. Epub 2021 Mar 9.
Magnetic resonance spectroscopy (MRS) is capable of revealing important biochemical and metabolic information of tissues noninvasively. However, the low concentrations of metabolites often lead to poor signal-to-noise ratio (SNR) and a long acquisition time. Therefore, the applications of MRS in detection and quantitative measurements of metabolites in vivo remain limited. Reducing or even eliminating noise can improve SNR sufficiently to obtain high quality spectra in addition to increasing the number of signal averaging (NSA) or the field strength, both of which are limited in clinical applications. We present a Spectral Wavelet-feature ANalysis and Classification Assisted Denoising (SWANCAD) approach to differentiate signal and noise peaks in magnetic resonance spectra based on their respective wavelet features, followed by removing the identified noise components to improve SNR. The performance of this new denoising approach was evaluated by measuring and comparing SNRs and quantified metabolite levels of low NSA spectra (e.g. NSA = 8) before and after denoising using the SWANCAD approach or by conventional spectral fitting and denoising methods, such as LCModel and wavelet threshold methods, as well as the high NSA spectra (e.g. NSA = 192) recorded in the same sampling volumes. The results demonstrated that SWANCAD offers a more effective way to detect the signals and improve SNR by removing noise from the noisy spectra collected with low NSA or in the subminute scan time (e.g. NSA = 8 or 16 s). The potential applications of SWANCAD include using low NSA to accelerate MRS acquisition while maintaining adequate spectroscopic information for detection and quantification of the metabolites of interest when a limited time is available for an MRS examination in the clinical setting.
磁共振波谱(MRS)能够无创地揭示组织重要的生化和代谢信息。然而,代谢物的低浓度常常导致信噪比(SNR)不佳以及采集时间过长。因此,MRS在体内代谢物检测和定量测量中的应用仍然有限。除了增加信号平均次数(NSA)或场强(这两者在临床应用中都受到限制)之外,减少甚至消除噪声可以充分提高SNR以获得高质量的波谱。我们提出了一种基于磁共振波谱中信号和噪声峰各自的小波特征来区分它们的谱小波特征分析和分类辅助去噪(SWANCAD)方法,随后去除识别出的噪声成分以提高SNR。通过测量和比较使用SWANCAD方法或传统谱拟合及去噪方法(如LCModel和小波阈值方法)去噪前后低NSA波谱(例如NSA = 8)以及在相同采样体积中记录的高NSA波谱(例如NSA = 192)的SNR和定量代谢物水平,来评估这种新去噪方法的性能。结果表明,SWANCAD提供了一种更有效的方法来检测信号,并通过从低NSA或在亚分钟扫描时间(例如NSA = 8或16秒)收集的噪声波谱中去除噪声来提高SNR。SWANCAD的潜在应用包括在临床环境中进行MRS检查时间有限时,使用低NSA来加速MRS采集,同时保持足够的波谱信息用于检测和定量感兴趣的代谢物。